INTEGRIS Cancer Institute of Oklahoma — Oklahoma City, Oklahoma

INTEGRIS Cancer Institute of Oklahoma is a clinical research site located in Oklahoma City, Oklahoma, United States 73109.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

INTEGRIS Cancer Institute of Oklahoma has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Primary Immune Thrombocytopenia (ITP).

Sponsors: argenx.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for INTEGRIS Cancer Institute of Oklahoma?

INTEGRIS Cancer Institute of Oklahoma has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has INTEGRIS Cancer Institute of Oklahoma conducted?

INTEGRIS Cancer Institute of Oklahoma has 1 clinical trials on record, with 1 currently active. Their work covers Primary Immune Thrombocytopenia (ITP).

Is INTEGRIS Cancer Institute of Oklahoma accredited by Crixeo Health?

INTEGRIS Cancer Institute of Oklahoma has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about INTEGRIS Cancer Institute of Oklahoma?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.